Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 2/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.38 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.36 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 3/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | GLP1R | P43220 | 3/20 | 0.35 |
| ▸ | BMP1 | P13497 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17793216 | 0.75 | NOD1 (0.53) | NOD1SLC6A5PLA2G2CPLA2G10 | |
| SCHEMBL20257262 | 0.72 | FNTA (0.42) | CASP1BMP1 | |
| SCHEMBL14048819 | 0.72 | CASP3 (0.48) | CASP1CASP3 | |
| SCHEMBL13019043 | 0.72 | CASP3 (0.48) | CASP1CASP3 | |
| SCHEMBL13018867 | 0.72 | CASP3 (0.48) | CASP1CASP3 | |
| SCHEMBL13020570 | 0.72 | CASP3 (0.48) | CASP1CASP3 | |
| SCHEMBL13776558 | 0.71 | CA2 (0.51) | CASP1CASP3 | |
| SCHEMBL27410587 | 0.71 | NOD1 (0.43) | NOD1EPHX2PLA2G2CPLA2G10BMP1 | |
| SCHEMBL12809931 | 0.70 | CASP3 (0.45) | CASP1CASP3 | |
| SCHEMBL7275500 | 0.70 | CASP3 (0.45) | CASP1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3733683-A1 | NUCLEOSIDE ANALOGUE, PREPARATION METHOD AND APPLICATION | GeneMind Biosciences Company Limited (CN) | 2020-11-04 | — | — | EP | disclosed |